Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1649_Библиотеки_им_академика_М_И_Перельмана.pdf
Management of Acute Biliary Pancreatitis
131
[24] Makhija, R; Kingsnorth, AN. Cytokine storm in acute pancreatitis. J
Hepatobiliary Pancreat Surg, 2002, 9, 401 – 410.
[25] Lipsett, PA. Serum cytokines, proteins, and receptors in acute
pancreatitis: mediators, markers, or more of the same? Crit Care Med,
2001, 29, 1642 – 1644.
[26] Pezzilli, R; Maldini, K; Morselli – Labate, AM; et al. Early activation of
peripheral lymphocytes in human acute pancreatitis. J Clin
Gastroenterol, 2003, 36, 360 – 363.
[27] Poch, B; Gansauge, F; Rau, B; et al. The role of polymorphonuclear
leukocytes and oxygen-derived free radicals in experimental acute
pancreatitis: mediators of local destruction and activators of
inflammation. FEBS Letters, 1999, 461, 268 – 272.
[28] Sakai, Y; Madamune, A; Satoh, A; et al. Macrophage migration
inhibitory factor is a critical mediator of severe acute pancreatitis.
Gastroenterology, 2003, 124, 725 – 736.
[29] Guzman, EA; Rudnicki, M. Intricacies of host response in acute
pancreatitis. J Am Coll Surg, 2006, 202, 509 – 519.
[30] Deitch, EA; Xu, DZ; Qi, L; et al. Bacterial translocation from the gut
impairs systemic immunity. Surgery, 1991, 109, 269 – 276.
[31] Fu, CY; Yeh, CN; Hsu, JT; et al. Timing of mortality in severe acute
pancreatitis: experience from 643 patients. World J Gastroenterol, 2007,
13, 1966 – 1969.
[32] Durganpudi, C; Noel, P; Patel, K; et al. Acute lipotoxicity regulates
severity of biliary acute pancreatitis without affecting its initation. Am J
Pathol, 2014, 184, 1773 – 1784.
[33] Inoul, H; Nakagawa, Y; Ikemura, M; et al. Molecular – biological
analysis of acute lung injury (ALI) induced by heat exposure and/or
intravenous administration of oleic acid. Leg Med (Tokyo), 2012, 14, 304
– 308.
[34] Ishola, DA; jr. Post, IA; van Timmereu, MM; et al. Albumin bound fatty
acids induce mithocondrial oxidant stress and impair antioxidant
responses in proximal tubular cells. Kidney int, 2006, 70, 724 – 731.
[35] Noel, P; Patel, K; Durganpudi, C; et al. Peripancreatic fat necrosis
worsens acute pancreatitis independent of pancreatic necrosis via
unsaturated fatty acids increased in human pancreatic necrosis
collections. GUT, Published Online First Dec 10 2014, 1-12.
[36] Banks, PA; Freeman, ML. Practice guidelines in acute pancreatitis. Am J
Gastroenterol, 2006, 101, 2379 – 2400.
Vincenzo Neri
132
[37] Yadav, D; Agarwal, N; Pitchumoni, CS. A critical evaluation of
laboratory tests in acute pancreatitis. Am J Gastroenterol, 2002 Jun
97(6), 1309 – 1318.
[38] Wilson, C; Heads, A; Shenkin, A; et al. C-reactive protein, antiproteases
and complement factors as objective markers of severity in acute
pancreatitis; Br J Surg, 1989 Feb, 76 (2), 177 – 181.
[39] Gurleyik, G; Emir, S; Kilicoglu, G; et al. Computed tomography severity
index, APACHE II score, and serum CRP concentration for predicting
the severity of acute pancreatitis. JOP, 2005 Nov 10, 6(6), 562 – 567.
[40] Pindak, D; Parrak, V; Pechan, et al. The clinical value of procalcitonin in
prediction of severity and outcome in acute pancreatitis.
Hepatogastroenterology, 2003 Dec, 50 Suppl 2, 208-209.
[41] Jiang, CF; Shiau, YC; Ng, KW; et al. Serum interleukin-6, tumor
necrosis factor alpha and C-reactive protein in early prediction of
severity of acute pancreatitis; J Chin Med Assoc, 2004 Sep, 67 (9), 442-
446.
[42] Barauskas, G; Svagzdys, S; Maeckas, A. C-reactive protein in early
prediction of pancreatic necrosis. Medicina (Kaunas), 2004, 40 (2), 135
– 140.
[43] Del Prete, M; Castiglia, D; Meli, M; et al. Prognostic value of C-reactive
protein in acute pancreatitis. Chir Ital, 2001 Jan- Feb, 53 (1), 33-38.
[44] Ignjatovic, S; Majkic-Singh, N; Mitovic, M; et al. Biochemical
evaluation of patients with acute pancreatitis, Clin Chem Lab Med, 2000
Nov, 38 (11), 1141-1144.
[45] Mayer, JM; Raraty, M; Slavin, J; et al. Serum amyloid A is a better early
predictor of severity than C-reactive protein in aute pancreatitis. Br J
Surg, 2002 Feb, 89(2), 163-171.
[46] Triester, SL; Kowdley, KV. Prognostic factors in acute pancreatitis. J
Clin Gastroenterol, 2002 Feb, 34(2), 167 – 176.
[47] Sandberg, AA; Borgstorm, A. Early prediction of severity in acute
pancreatitis. Is this possible? JOP, 2002 Sep 3(5), 116-125.
[48] Neoptolemos, JP; Kemppainen, EA; Mayer, JM; et al. Early prediction
of severity in acute pancreatitis by urinary trypsinogen activation
peptide: a multicentre study; Lancet, 2000 Jun 3, 355(9219), 1955-1960.
[49] Johnson, CD; Lempinem, M; Imrie, CW; et al. Urinary trypsinogen
activation peptide as a marker of severe acute pancreatitis; Br J Surg,
2004 Aug, 91 (8), 1027-1033.
Management of Acute Biliary Pancreatitis
133
[50] Liu, ZS; Jiang, CQ; Qian, Q; et al. Early prediction of severe acute
pancreatitis by urinary trypsinogen activation peptide. Hepatobiliary
Pancreat Dis Int, 2002 May, 1(2), 285-289.
[51] Khan, Z; Vlodov, J; Horovitz, J; et al. Urinary trypsinogen activation
peptide is more accurate than hematocrit in determing severity in
patients with acute pancreatitis: a perspective study; Am J Gastroenterol,
2002 Aug, 97 (8), 1973-1977.
[52] Lempinen, M; Kylanpaa – Back, ML; Stenman, UH; et al. Predicting the
severity of acute pancreatitis by rapid measurement of trypsinogen-2 in
urine. Clin Chem, 2001 Dec, 47 (12), 2103, 7.
[53] Bulbuller, N; Dogru, O; Ayten, R; et al. Procalcitonin is a predictive
marker for severe acute pancreatitis. Ulus Tramva Acil Cerrahi Derg,
2006 Apr, 12 (2), 115-120.
[54] Modrau, IS; Floyd, AK; Thorlacius – Ussing, O. The clinical value of
procalcitonin in early assessment of acute pancreatitis; Am J
Gastroenterol, 2005 Jul, 100(7), 1593-1597.
[55] Rau, B; Schilling, MK; Beger, HG. Laboratory markers of severe acute
pancreatitis. Dig Dis, 2004, 22(3), 247-257.
[56] Yonetci, N; Sungurtekin, U; Oruc, N; et al. Is procalcitonin a reliable
marker for the diagnosis of infected pancreatic necrosis? Am J Surg,
2004 JUL, 74 (7), 591-595.
[57] Ammori, BJ; Becker, KL; Kite, P; et al. Calcitonin precursors: early
markers of gut barrier dysfunction in patients with acute pancreatitis.
Pancreas, 2003 Oct, 27(3), 239-243.
[58] Ammori, BJ; Becker, KL; Kite, P; et al. Calcitonin precursors in the
prediction of severity of acute pancreatitis on the day of admission. Br J
Surg, 2003 Feb, 90(2), 197-204.
[59] Mandi, Y; Farkas, G; Takacs, T; et al. Diagnostic relevance of
procalcitonin, IL-6, and sICAM-1 in the prediction of infected necrosis
in acute pancreatitis. Int J Pancreatol, 2000 Aug, 28(1), 41-49.
[60] Kylanpaa-Back, ML; Takala, A; Kemppainen, EA; et al. Procalcitonin,
soluble interleukin-2 receptor and E-selectine in predicting the severity
of acute pancreatitis. Crit Care med, 2001 Jan (1), 63-69.
[61] Remes-Troche, JM; Duarte – Rojo, A; Morales, G; et al.
Hemoconcentration is a poor predictor of severity in acute pancreatitis.
World J Gastroenterol, 2005 Nov 28, 11(44), 7018-7023.
[62] Lankisch, PG; Blum, T; et al. Hemoconcentration: an early marker of
severe and/or necrotizing pancreatitis? A critical apparisal. Am J
Gastroenterol, 2001 Jul, 96 (7), 2081-2085.
Vincenzo Neri
134
[63] Lankisch, PG; Blum, T; Maisonneuve, P; et al. Severe acute pancreatitis:
whn to be concerned? Pancreatology, 2003, 3(2), 102-110.
[64] Gan, SI; Romagnuolo, J. Admission hematocrit: a simle, useful and early
predictor of severe pancreatitis; Dig Dis Sci, 2004 Nov-Dec, 49 (11-12),
1946-1952.
[65] Meek, K; Toosie, K; Stabile, BE; et al. Simplified admission criterion
for predicting severe complications of gallstone pancreatitis. Arch Surg,
2000 Sep, 135 (9), 1048-1052.
[66] Lankisch, PG; Blum, T; Burns, A; et al. Has blood glucose level
measured ao admission to hospital in a patient with acute pancreatitis
any prognostic value? Pancreatology, 2001, 1 (3), 224-229.
[67] Meek, K; de Virgilio, C; Murrel, Z; et al. Correlation between admission
laboratory values, early abdominal computed tomography and severe
complications of gallstones pancreatitis. Am J Surg, 2000 Dec, 180 (6),
556-560.
[68] Gurleyik, G; Emir, S; Kilicoglu, G; et al. Computed tomography severity
index, APACHE II score, and serum CRP concentration for predicting
the severity of acute pancreatitis. JOP, 2005 Nov 10, 6(6), 562 – 567.
[69] Liu, ZS; Jiang, CQ; Qian, Q; et al. Early prediction of severe acute
pancreatitis by urinary trypsinogen activation peptide. Hepatobiliary
Pancreat Dis Int, 2002 May, 1(2), 285-289.
[70] Gan, SI; Romagnuolo, J. Admission hematocrit: a simle, useful and early
predictor of severe pancreatitis; Dig Dis Sci, 2004 Nov-Dec, 49 (11-12),
1946-1952.
[71] Roseano, M; Lovadina, S; Calligaris, L; et al. The multidisciplinary
management of acute pancreatitis: a review of 244 cases. Ann Ital Chir,
2004 Jul-Aug, 75 (4), 443-453.
[72] Mentula, P; Kylanpaa, ML; Kemppainen, E; et al. Early prediction of
organ failure by combined markers in patients with acute pancreatitis. Br
J Surg, 2005 Jan, 92 (1), 68-75.
[73] Kong, L; Santiago, N; Han, TQ; et al. Clinical characteristic and
prognostic factors of severe acute pancreatitis. World J Gastroenterol,
2004 Nov 15, 10 (22), 2226-2228.
[74] Taylor, SL; Morgan, DL; Denson, KD; et al. A comparison of Ranson,
Glasgow, APACHE II scoring systems to a multiple organ system score
in predicting patient outcome in pancreatitis. Am J surg, 2005 Feb, 189
(2), 219-222.
Management of Acute Biliary Pancreatitis
135
[75] Poves Prim, I; Fabregat Pous, J; Garcia Borobia, FJ; et al. Early onset of
organ failure is the best predictor of mortality in acute pancreatitis. Rev
Esp Enferm Dig, 2004 Oct, 96(10), 705-9, 709-713.
[76] Halonen, KI; Lappaniemi, AK; Lundin, JE; et al. Predictin fatal outcome
in the early phase of severe acute pancreatitis by using novel prognostic
models. Pancreatology, 2003, 3(4), 309-315.
[77] Company, L; Saez, J; Martinez, J; et al. Factors predicting mortality in
severe acute pancreatitis. Pancreatology, 2003, 3(2), 144-148.
[78] Liu, YH; Kwonh, KL; Tamm, EP; et al. Acute pancreatitis in intensive
care unit patients: value of clinical and radiologic prognostic factors as
predicting clinical course and outcome. Crit Care Med, 2003 Apr, 31(4),
1026-1030.
[79] Khan, AA; Parekh, D; Cho, Y; et al. Improved prediction of outocme in
patients with severe acute pancreatitis by the APACHE II score at 48
hours afters admission compared with the APACHE II score at
admission. Acute physiology and chronic health evaluation. Arch Surg,
2002 Oct, 137(10), 1136-1140.
[80] Eachempati, SR; Hydo, LJ; Barie, PS. Severity scoring for
prognostication in patients with severe acute pancreatitis: comparative
analysis of the Ranson score and APACHE III score. Arch Surg, 2002
Jun, 137 (6), 730-736.
[81] Osvaldt, AB; Viero, P; Bordeg da Costa, MS; et al. Evaluation of
Ranson, Glasgow, APACHE II and APACHE-Q criteria to predict
severity in acte biliar pancreatitis. Int Surg, 2001 Jul-Sep, 86 (3), 158-
161.
[82] Gemelli, F; Magon, R. Semplified prognostic test in early detection of
acute pancreatitis. Minerva Med, 2002 Feb 93(1), 1-5.
[83] Lankisch, PG; Weber-Dany, B; Hebel, K; et al. The hamless acute
pancreatitis score: a clinical algorithm for rapid initial stratification of
non severe disease. Clin Gastroenterol Hepatol, 2009, 7, 702 – 705.
[84] Wu, BU; Johannes, RS; Sun, X; et al. The early prediction of mortality
in acute pancreatitis: a large population based study. GUT, 2008, 57,
1698 – 1703.
[85] Balthazar, EJ; Robinson, DL; Megibow, AJ; et al. Acute pancreatitis:
value of CT in establishing prognosis. Radiology, 1990, 174, 331-336.
[86] Balthazar, EJ; Freeny, PC; Vansonnenberg, E. Imaging and intervention
in acute pancreatitis. Radiology, 1994, 193 (2), 297 – 306.
[87] Balthazar, EJ. Acute pancreatitis: assessment of severity with clinical
and CT-evaluation. Radiology, 2002, 223, 603 – 613.
Vincenzo Neri
136
[88] Delrue, LJ; De Waele, JJ; Durjck, PO. Acute pancreatitis: radiologic
scores in predicting severity and outcome. Abdom Imaging, 2010, 35,
349-361.
[89] Bollen, TL; Singh, UK; Maure, R. Comparative evaluation of the
modified CT severity index and CT severity index in assessing severity
of acute pancreatitis. Am J Roentgenol, 2011, 197, 386-92.
[90] Aggarwal, A; Maurai, M; Kochhar, R. Fluid resuscitation in acute
pancreatitis. World J Gastroenterol, 2014, 20(48), 18092-18103.
[91] Gardner, TB; Vege, SS; Pearson, RK; et al. Fluid resuscitation in acute
pancreatitis. Clin Gastroenterol Hepatol., 2008, 6, 1070 – 1076.
[92] Hazen, ZN. Acute biliary pancreatitis: diagnosis and treatment. Saudi J
Gastroenterol, 2009, 15(3), 147-155.
[93] Gupta, R; Patel, K; Calder, PC; et al. Randomized clinical trial to assess
the effect of total enteral and total parenteral nutritional support on
metabolic, inflammatory and oxidative markers in patients with
predicted severe acute pancreatitis (APACHE II > 6). Pancreatology,
2003, 3, 406-413.
[94] Pezzilli, R; Zerbi, A; Di Carlo, V; et al. Working group of the italian
Association for the study of the pancreas on Acute pancreatitis. Pratical
Guidelines for Acute pancreatitis. Pancreatology, 2010, 10, 523 – 535.
[95] Bassi, C; Pederzoli, P; Vasentini, S; et al. Behaviour of antibiotic during
necrotizing pancreatitis. Antimicrob agents chemiother., 1994, 38, 830-
836.
[96] Besselink, MG; van Santvoort, HC; Boermeester, MH; et al. Timing and
impact of infections in acute pancreatitis. Br J Surg, 2009, 96, 267 –
273.
[97] Manes, G; Uomo, I; Menchise, A; et al. Timing of antibiotics
prophylaxis in acute pancreatitis: a controlled randomized study with
meropenem. Am J Gastroenterol., 2006, 101, 1348 – 1353.
[98] Seta, T; Noguchi, Y; Schimada, T; et al. Treatment of acute pancreatitis
with protease inhibitor: a meta-analysis. Eur J Gastroenterol Hepatol,
2004, 16, 1286 – 1293.
[99] Heinrich, S; Schafer, M; Rousson, V; et al. Evidence – based treatment
of acute pancreatitis: a look at establishment paradigms. Ann Surg, 2006,
243, 154 – 168.
[100] Beger, HG; Rau, BM. Severe acute pancreatitis: clinical course and
management, 2007, 13 (38), 5043 – 5051.
Management of Acute Biliary Pancreatitis
137
[101] Neri, V; Lapolla, F; Di Lascia, A; et al. Defining a therapeutic program
for recurrent acute pancreatitis patients with unknown etiology. Clinical
Med Insights: Gastroenterology, 2014, 7, 1-7.
[102] Neoptolemos, JP; Carr-Locke, DL; London, NJ; et al. Controlled trial of
urgent endoscopic retrograde cholangiopancreatography and endoscopic
sphincterotomy versus conservative treatment for acute pancreatitis due
ti gallstones. Lancet, 1988, 2, 979-983.
[103] Fan, FT; Lai, EC; Mok, FP; et al. Early tretment of acute biliary
pancreatitis by endoscopic papillotomy. N Eng J Med, 1993, 328, 228-
232.
[104] Nowak, A; Nowakowska – Dulawa, E; Marek, TA; et al. Final results of
the prospective, randomized, controlled study on endoscopic
sphincterotomy versus conventional management in acute biliary
pancreatitis (abstract). Gastroenerology, 1995, 108, A380.
[105] Folsch, UR; Nitsche, R; Ludtke, R; et al. Early ERCP and papillotomy
compared with conservative treatment for acute biliary pancreatitis. The
German Study Group on Acute Biliary Pancreatitis. N Engl J Med, 1997,
336, 237-242.
[106] Behrns, KE; Ashley, SW; Hunter, JG; et al. Early ERCP for gallstone
pancreatitis: for whom and when? J Gastroenterol Surg, 2008, 12, 629-
633.
[107] Petrov, MS; Uchugina, AF; Kukosh, MV. Does endoscopic retrograde
cholangiopancreatography reduce risk of local pancreatic complications
in acute pancreatitis? Gastrointest Surg, 2008, 12, 629-633.
[108] Moretti, A; Papi, C; Aratari, A; et al. Is early endoscopic retrograde
cholangiopancreatography useful in the management of acute biliary
pancreatitis? A meta – analysis of randomized controlled trials. Dig
Liver Dis, 2008, 40, 379-385.
[109] Tse, F; Youan, Y. Early routine endoscopic retrogade
cholangiopancreatography strategy versus early conservative
management strategy in acute gallstone pancreatitis. Cochrane Database
Syst Rev, 2010, 5, CD009779.
[110] Freeman, ML. Adverse outcomes of endoscopic retrograde
cholangiopancreatography. Rev. Gastroenterol Disord, 2002, 2, 147 –
168.
[111] Davis, WZ; Cotton, PB; Arias, R; et al. ERCP and sphincterotomy in the
context of laparoscopic cholecystectomy: academic and community
practice patterns and results. Am J Gastroenterol, 1997, 92(4), 597-601.
Vincenzo Neri
138
[112] Andriulli, A; Loperfido, S; Napolitano, G; et al. Incidence rates of post
ERCP complications: a systematic survey of prospective study. Am J
Gastroenterol, 2007, 102(8), 1781 – 1788.
[113] Gooszen, HG; Besselink, MG; van Santvoort, HC; et al. Surgical
treatment of acute pancreatitis. Langenbecks Arck Surg., 2013, 398, 799
– 806.
[114] Zerem, E; Imamovic, G; Omesovic, S; et al. Randomized controlled trial
on sterile fluid collections management in acute pancreatitis: should they
be revomed? Surg Endosc., 2009, 23(12), 2770 – 2777.
[115] Tsiotos, GG; Luque, LC; Sorcide, JA; et al. Management of necrotizing
pancreatittis by repeated operative necrosectomy using a zipper
techinque. Am J Surg., 1998, 175, 1 – 92.
[116] Banks, PA; Gerzof, SG; Langevin, RE; et al. CT-guided aspiration
suspected pancreatic infection: bacteriology and clinical outcome. Int J
Pancreatol, 1995, 18, 265 – 279.
[117] Petrov, MS; Shanbhag, S; Chakreborty, M; et al. Organ failure and
infection of pancreatic necrosis as determinants of mortality in patients
with acute pancreatitis. Gastroenterology, 2010, 139, 813 – 820.
[118] McKay, CJ; Imrie, CW. The continuing challenge of early mortality in
acute pancreatitis. Br J Surg, 2004, 91, 1243 – 1244.
[119] Carter, CR; McKey, CJ. Management in necrotizing pancreatitis in: KJ
Bland et al. (eds). Surgery of the pancreas and spleen. Springer Verlag
London Limited, 2001 p 3 – 15.
[120] Van Baal, MC; van Santvoort, HC; Bollen, TL; et al. Systematic review
of percutaneous catheter drainage as primary treatment for necrotizing
pancreatitis. Brit J Surg, 2011, 98(1), 18 – 27.
[121] Ran, B; Bothe, A; Beger, HG. Surgical treatment of necrotizing
pancreatitis by necrosectomy and closed lavage: changing patient
characteristics and outcome in a 19.years, single center series. Surgey,
2005, 138(1), 28 – 39.
[122] Rodriguez, JR; Razo, AO; Targarona, J; et al. Debridment and closed
packing for sterile or infected necrotizing pancreatitis: insight into
indications and outcomes in 167 patients. Ann Surg, 2008, 247(2), 249 –
299.
[123] Raraty, MG; Halloran, CM; Dodd, S; et al. Minimal access
retroperitoneal pancreatic necrosectomy: improvement in morbidity and
mortality with a less invasive approach. Ann Surg, 2010, 251(5), 787-
793.
Management of Acute Biliary Pancreatitis
139
[124] Horvath, K; Freeny, P; Escallon, J; et al. Safety and efficacy of video-
assisted retroperitoneal debridement for infected pancreatic collections:
a multicenter, prospective, single-arm phase 2 study. Arch Surg, 2010,
145(9), 817-825.
[125] van Santvoort, HC; Besselink, MG; Horvath, KD; et al. Videoscopic
assisted retroperitoneal debridement in infected necrotizing pancreatitis.
HPB, 2007, 9(2), 156-159.
[126] Bakker, OJ; van Santvoort, HC; van Brunschot, S; et al. Endoscopic
transgastric vs surgical necrosectomy for infected necrotizing
pancreatitis: a randomized trial. JAMA, 2012, 307(10), 1053-1061.
[127] van Santvoort, HC; Besselink, MG; Bakker, OJ; et al. A step-up
approach or open necrosectomy for necrotizing pancreatitis. N Eng J
Med, 2010, 362(16), 1491-1506.
[128] Dua, MM; Worhunsky, DJ; Tran, TB; et al. Surgical strategies for the
management of necrotizing pancreatitis. JOP J Pancreas (online),
2015(9), 16(6), 547 – 558.
[129] Carter, CR. Percutaneous management of necrotizing pancreatitis. HPB,
2007, 9(3), 235 – 239.
[130] Naoum, E; Zavos, A; Gaudis, K; et al. Pancreatic pseudocysts: 10 years
of experience. J Hepatol. Pancreat Surg, 2003, 10, 373 – 376
[131] Ferrucci, J; Muller, P. Interventional approach to pancreatic fluid
collections. Radial Clin North Am., 2003, 41, 1217 – 1226.
BIOGRAPHICAL SKETCH
Vincenzo Neri, Prof Dr Med
General Surgery, University of Foggia, Italy
Full Professor of General Surgery, University of Foggia, Italy
V. G. Murat 46, Bari (71023) Italy
Research and Professional Experience:
Director of the Division of General Surgery (1997- today)
Director of Residency School of General Surgery, Policlinic University of
Foggia (2008-today)
Assistant Professor from 1974 to 1982 (University of Bari – Italy).
Associate Professor from 1982-2001 (University of Bari – Italy).
He obtained the Diploma of “Maitrise Universitaire en Pedagogie des
Sciences de la Santé” on the Université Paris-Nord Bobigny.
Vincenzo Neri
140
Into ERASMUS-Program 2010-2011 he developed in the University of
Gent (BE) a seminare on “Cystic tumours of the pancreas.”
He was the President of the Course of Degree of Medicine and Surgery,
University of Foggia from 1996 to 2002.
He was Director of Department of Surgical Sciences, University of
Foggia, from 2002 to 2008.
Research’s interest: Hepatobiliarypancreatic Surgery.
Publications Last Three Years:
Laparoscopic Treatment of Hepatic Cysts: A 10-Years Single Institution
Experience.
Nicola Tartaglia · Alessandra Lascia · Pasquale Cianci · Alberto Fersini ·
Vincenzo Lizzi · Antonio Ambrosi · Vincenzo Neri. British Journal of
Medicine and Medical Research 12(3): 1-10, 2016, Article no.
BJMMR.22140 ISSN: 2231-0614, NLM ID: 101570965.
Spleen assessment after laparoscopic transperitoneal left adrenalectomy:
preliminary results.
Cianci P, Fersini A, Tartaglia N, Altamura A, Lizzi V, Stoppino LP, Macarini
L, Ambrosi A, Neri V. Surg Endosc. 2015 Jul 3.
Voluminous omental inflammatory myofibroblastic tumor in an elderly man: a
case report and literature review.
Cianci P, Ambrosi A, Fersini A, Tartaglia N, Lizzi V, Sanguedolce F,
Parafioriti A, Neri V. Case Rep Surg. 2015;2015:873758. doi:
10.1155/2015/873758. Epub 2015 Jan 22.
Laparoscopic cholecystectomy: evaluation of liver function tests. Neri V,
Ambrosi A, Fersini A, Tartaglia N, Cianci P, Lapolla F, Forlano I. Ann
Ital Chir. 2014 Sep-Oct; 85(5): 431-7.
Defining a therapeutic program for recurrent acute pancreatitis patients with
unknown etiology. Neri V, Lapolla F, Di Lascia A, Giambavicchio LL.
Clin Med Insights Gastroenterol. 2014 Jan 5; 7: 1-7. doi:
10.4137/CGast.S13531. eCollection 2014.
Multiple skeletal muscle metastases from colon carcinoma preceded by
paraneoplastic dermatomyositis.
Landriscina M, Gerardi AM, Fersini A, Modoni S, Stoppino LP, Macarini L,
Sanguedolce F, Bufo P, Neri V. Case Rep Med. 2013;2013:392609. doi:
10.1155/2013/392609. Epub 2013 Jul 24.
Common bile duct lithiasis: therapeutic approach. Neri V, Ambrosi A, Fersini
A, Tartaglia N, Lapolla F. Ann Ital Chir. 2013 Jul-Aug; 84(4): 405-10.
Review.